Johnson & Johnson must pay $8BN over drug side effect – jury

5

NEW YORK – A Pennsylvania jury ruled Tuesday that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that a psychiatric drug could cause breast growth in men.

Johnson & Johnson and its subsidiary Janssen Pharmaceuticals were blamed as plaintiff Nicholas Murray told the Philadelphia court that the drug Risperdal, prescribed to treat schizophrenia and bipolar disorder, had made him grow breasts.

The company challenged the ruling in a statement, calling the damages awarded “grossly disproportionate” with the initial award in the case of $680,000.

Read more